Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia.

Hdl Handle:
http://hdl.handle.net/10147/200247
Title:
Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia.
Authors:
Langabeer, Stephen E; Crampe, Mireille; Haslam, Karl; Kelly, Johanna; Cahill, Mary R
Citation:
Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia. 2010, 34 (7):e176-7 Leuk. Res.
Journal:
Leukemia research
Issue Date:
Jul-2010
URI:
http://hdl.handle.net/10147/200247
DOI:
10.1016/j.leukres.2010.01.025
PubMed ID:
20153526
Item Type:
Article
Language:
en
MeSH:
Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Fusion Proteins, bcr-abl; Humans; Incidental Findings; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; RNA, Messenger; RNA, Neoplasm; Remission Induction; Tumor Markers, Biological
ISSN:
1873-5835

Full metadata record

DC FieldValue Language
dc.contributor.authorLangabeer, Stephen Een
dc.contributor.authorCrampe, Mireilleen
dc.contributor.authorHaslam, Karlen
dc.contributor.authorKelly, Johannaen
dc.contributor.authorCahill, Mary Ren
dc.date.accessioned2012-01-05T12:38:28Z-
dc.date.available2012-01-05T12:38:28Z-
dc.date.issued2010-07-
dc.identifier.citationSustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia. 2010, 34 (7):e176-7 Leuk. Res.en
dc.identifier.issn1873-5835-
dc.identifier.pmid20153526-
dc.identifier.doi10.1016/j.leukres.2010.01.025-
dc.identifier.urihttp://hdl.handle.net/10147/200247-
dc.language.isoenen
dc.subject.meshAntineoplastic Agents-
dc.subject.meshDrug Resistance, Neoplasm-
dc.subject.meshFemale-
dc.subject.meshFusion Proteins, bcr-abl-
dc.subject.meshHumans-
dc.subject.meshIncidental Findings-
dc.subject.meshLeukemia, Myelogenous, Chronic, BCR-ABL Positive-
dc.subject.meshMiddle Aged-
dc.subject.meshPiperazines-
dc.subject.meshProtein Kinase Inhibitors-
dc.subject.meshPyrimidines-
dc.subject.meshRNA, Messenger-
dc.subject.meshRNA, Neoplasm-
dc.subject.meshRemission Induction-
dc.subject.meshTumor Markers, Biological-
dc.titleSustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia.en
dc.typeArticleen
dc.identifier.journalLeukemia researchen
dc.description.provinceMunster-
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.